Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation
A. Cheng, I. Kawahata, Y. Wang, W. Jia, T. Sekimori, Y. Chen, N. Stefanova, D. I. Finkelstein, W. Ma, M. Chen, T. Sasaki, K. Fukunaga
This study identifies epsin-2 as a therapeutic target for multiple system atrophy by regulating FABP7/-synuclein hetero-aggregates propagation.
bioRxiv · Jun 16, 2022Pathology